Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

<p>Abstract</p> <p>Background</p> <p>To assess the outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with a high risk of lo...

Full description

Bibliographic Details
Main Authors: Narita Shintaro, Tsuchiya Norihiko, Kumazawa Teruaki, Maita Shinya, Numakura Kazuyuki, Obara Takashi, Tsuruta Hiroshi, Saito Mitsuru, Inoue Takamitsu, Horikawa Yohei, Satoh Shigeru, Nanjyo Hiroshi, Habuchi Tomonori
Format: Article
Language:English
Published: BMC 2012-01-01
Series:World Journal of Surgical Oncology
Subjects:
chemohormonal therapy
prostate cancer
docetaxel
estramustine phosphate
complete androgen blockade
androgen deprivation
Online Access:http://www.wjso.com/content/10/1/1

Internet

http://www.wjso.com/content/10/1/1

Similar Items